INBS
INBS
NASDAQ · Health Care

Intelligent Bio Solutions In

$2.96
-0.26 (-8.07%)
Financial Highlights (FY 2026)
Revenue
11.45M
Net Income
-39,638,762
Gross Margin
40.8%
Profit Margin
-346.2%
Rev Growth
+91.1%
D/E Ratio
0.07
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 40.8% 40.8% 43.3% 43.3%
Operating Margin -348.7% -313.8% 14.6% 14.1%
Profit Margin -346.2% -328.9% 12.3% 12.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 11.45M 5.99M 2.43M 2.55M
Gross Profit 4.68M 2.45M 1.05M 1.11M
Operating Income -39,922,751 -18,798,972 355.4K 360.4K
Net Income -39,638,762 -18,665,246 299.8K 314.6K
Gross Margin 40.8% 40.8% 43.3% 43.3%
Operating Margin -348.7% -313.8% 14.6% 14.1%
Profit Margin -346.2% -328.9% 12.3% 12.3%
Rev Growth +91.1% +91.1% +12.5% -7.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 210.0K 210.0K 3.58M 2.96M
Total Equity 3.19M 3.19M 5.90M 5.31M
D/E Ratio 0.07 0.07 0.61 0.56
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -35,393,193 -17,591,970 505.3K 509.1K
Free Cash Flow 188.2K 257.9K